HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topical Losartan and Corticosteroid Additively Inhibit Corneal Stromal Myofibroblast Generation and Scarring Fibrosis After Alkali Burn Injury.

AbstractPurpose:
To evaluate the efficacy of losartan and prednisolone acetate in inhibiting corneal scarring fibrosis after alkali burn injury in rabbits.
Methods:
Sixteen New Zealand White rabbits were included. Alkali injuries were produced using 1N sodium hydroxide on a 5-mm diameter Whatman #1 filter paper for 1 minute. Four corneas in each group were treated six times per day for 1 month with 50 µL of (1) 0.8 mg/mL losartan in balanced salt solution (BSS), (2) 1% prednisolone acetate, (3) combined 0.8 mg/mL losartan and 1% prednisolone acetate, or (4) BSS. Area of opacity and total opacity were analyzed in standardized slit-lamp photos with ImageJ. Corneas in both groups were cryofixed in Optimal cutting temperature (OCT) compound at 1 month after surgery, and immunohistochemistry was performed for alpha-smooth muscle actin (α-SMA) and keratocan or transforming growth factor β1 and collagen type IV with ImageJ quantitation.
Results:
Combined topical losartan and prednisolone acetate significantly decreased slit-lamp opacity area and intensity, as well as decreased stromal myofibroblast α-SMA area and intensity of staining per section and confined myofibroblasts to only the posterior stroma with repopulation of the anterior and mid-stroma with keratocan-positive keratocytes after 1 month of treatment. Corneal fibroblasts produced collagen type IV not associated with basement membranes, and this production was decreased by topical losartan.
Conclusions:
Combined topical losartan and prednisolone acetate decreased myofibroblast-associated fibrosis after corneal alkali burns that produced full-thickness injury, including corneal endothelial damage. Increased dosages and duration of treatment may further decrease scarring fibrosis.
Translational Relevance:
Topical losartan and prednisolone acetate decrease myofibroblast-mediated scarring fibrosis after corneal injury.
AuthorsLycia Pedral Sampaio, Guilherme S L Hilgert, Thomas Michael Shiju, Marcony R Santhiago, Steven E Wilson
JournalTranslational vision science & technology (Transl Vis Sci Technol) Vol. 11 Issue 7 Pg. 9 (07 08 2022) ISSN: 2164-2591 [Electronic] United States
PMID35819289 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Adrenal Cortex Hormones
  • Alkalies
  • Collagen Type IV
  • Losartan
Topics
  • Adrenal Cortex Hormones (metabolism)
  • Alkalies (metabolism, toxicity)
  • Animals
  • Burns, Chemical (complications, drug therapy, metabolism)
  • Cicatrix (metabolism, pathology)
  • Collagen Type IV (metabolism)
  • Corneal Diseases (metabolism, pathology)
  • Corneal Injuries (complications, drug therapy, metabolism)
  • Fibrosis
  • Losartan (metabolism, pharmacology, therapeutic use)
  • Myofibroblasts (metabolism, pathology)
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: